ReviewCureus2025
Comprehension of PTEN-Regulated MicroRNA Profiling in Oral Premalignant Lesions: A Critical Link to Early Detection of Oral Squamous Cell Carcinoma.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral premalignant lesions represent the most prevalent lesions observed within the oral cavity. These lesions generally remain asymptomatic until they advance to more severe stages, at which point their progression to oral squamous cell carcinoma (OSCC) becomes evident. Addressing this transformation necessitates further investigative efforts. The PTEN (phosphatase and tensin homolog) gene functions as a crucial tumor suppressor, with its expression regulated by a variety of complex mechanisms, including transcriptional, post-transcriptional, and post-translational processes. MicroRNAs (miRNAs) are significant modulators of PTEN expression and play an integral role in the transition from oral premalignant lesions to OSCC. This review evaluates the impact of miRNA dysregulation on PTEN and examines the continuum model of tumor suppression. It posits that the loss of PTEN functionality may transpire without alterations to the DNA sequence, particularly through mechanisms associated with miRNA regulation. Furthermore, this discourse elucidates the structural interactions between PTEN and miRNAs, particularly in the context of oral premalignant lesions, which may influence the rate of transformation to OSCC. Such insights are crucial for informing treatment strategies. The review also explores the potential of targeting specific miRNAs to restore PTEN functionality, intending to improve clinical outcomes for patients diagnosed with OSCC. By elucidating these regulatory interactions, this analysis aims to identify pathways conducive to the development of targeted therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.